Long-Term Effect of Dipeptidyl Peptidase-IV Inhibitors on Cardiovascular Events in Type 2 Diabetes Mellitus Middle-Age Patients: A Meta-Analysis

被引：0
|
作者：
Patel, Samir [1 ]
Patel, Palak [2 ]
Patel, Mihir [3 ]
机构：
[1] Western Reserve Hlth Educ, NEOMED, Youngstown, OH USA
[2] Qingdao Med Coll, Qingdao, Peoples R China
[3] St Marys Hosp, Waterbury, CT USA
来源：
ENDOCRINE REVIEWS | 2014年 / 35卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT-0971
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Therapeutic potential of dipeptidyl peptidase-IV inhibitors in patients with diabetes mellitus
    Moore, Kevin B.
    Saudek, Christopher D.
    AMERICAN JOURNAL OF THERAPEUTICS, 2008, 15 (05) : 484 - 491
  • [2] Dipeptidyl peptidase-IV inhibitors: fixing type 2 diabetes?
    McIntyre, Hugh F.
    Grant, Paul
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2007, 68 (11) : 599 - 602
  • [3] Meta-Analysis of Effect of Dipeptidyl Peptidase-4 Inhibitors on Cardiovascular Risk in Type 2 Diabetes Mellitus
    Patil, Harshal R.
    Al Badarin, Firas J.
    Al Shami, Hamza A.
    Bhatti, Salman K.
    Lavie, Carl J.
    Bell, David S. H.
    O'Keefe, James H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2012, 110 (06): : 826 - 833
  • [4] Meta-analysis of dipeptidyl peptidase-4 inhibitors use and cardiovascular risk in patients with type 2 diabetes mellitus
    Kaneko, Masayuki
    Narukawa, Mamoru
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 116 : 171 - 182
  • [5] Incretin mimetics and dipeptidyl peptidase-IV inhibitors: Potential new therapies for type 2 diabetes mellitus
    Triplitt, C
    Wright, A
    Chiquette, E
    PHARMACOTHERAPY, 2006, 26 (03): : 360 - 374
  • [6] The effect of dipeptidyl peptidase-IV inhibition on circulating T cell subpopulations in patients with type 2 diabetes mellitus
    Sromova, Lucie
    Busek, Petr
    Posova, Helena
    Potockova, Jana
    Skrha, Pavel
    Andel, Michal
    Sedo, Aleksi
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 118 : 183 - 192
  • [7] The effect of dipeptidyl peptidase-IV inhibition on the immune functions in patients with type 2 diabetes
    Sromova, L.
    Busek, P.
    Mareckova, H.
    Potockova, J.
    Andel, M.
    Sedo, A.
    FEBS JOURNAL, 2014, 281 : 173 - 173
  • [8] Effects of Dipeptidyl Peptidase 4 Inhibitors and Sodium-Glucose Linked coTransporter-2 Inhibitors on cardiovascular events in patients with type 2 diabetes mellitus: A meta-analysis
    Savarese, Gianluigi
    D'Amore, Carmen
    Federici, Massimo
    De Martino, Fabiana
    Dellegrottaglie, Santo
    Marciano, Caterina
    Ferrazzano, Francesca
    Losco, Teresa
    Lund, Lars H.
    Trimarco, Bruno
    Rosano, Giuseppe M. C.
    Perrone-Filardi, Pasquale
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 220 : 595 - 601
  • [9] Longer term safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus: systematic review and meta-analysis
    Goossen, K.
    Graeber, S.
    DIABETES OBESITY & METABOLISM, 2012, 14 (12): : 1061 - 1072
  • [10] Meta-analysis of cardiovascular outcome trials assessing the cardiovascular efficacy and safety of dipeptidyl peptidase-4 inhibitors in patients with type 2 diabetes mellitus
    Patoulias, D.
    Boulmpou, A.
    Teperikidis, E.
    Katsimardou, A.
    Siskos, F.
    Tranidou, A.
    Nikolaidis, A.
    Mouselimis, D.
    Doumas, M.
    Papadopoulos, C. E.
    Vassilikos, V.
    EUROPEAN HEART JOURNAL, 2021, 42 : 2954 - 2954
12345